tiprankstipranks
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Want to see TSE:CRDL full AI Analyst Report?

Cardiol Therapeutics (CRDL) Revenue

221 Followers

Cardiol Therapeutics Revenue

Cardiol Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Mar 31, 2026, Cardiol Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
C$0
Employees
18
Market Cap
C$213.68M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2026
Mar 31, 2025
Mar 31, 2024
Dec 31, 2022
-78.76K-100.00%
Dec 31, 2021
78.76K+∞%
Mar 31, 2021
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017